Cargando…

Relationship between Patients' Baseline Characteristics and Survival Benefits in Immunotherapy-Treated Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: The difference of patients' baseline characteristics such as sex, age, Eastern Cooperative Oncology Group performance status (ECOG PS), and smoking status may influence the immune response. However, little is known about whether these factors affect the efficacy of immune checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xuanbo, Liu, Yafeng, He, Yuxiao, Wang, Zibo, Zhang, Hongyan, Yang, Wei, Lu, Jibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135521/ https://www.ncbi.nlm.nih.gov/pubmed/35646119 http://dx.doi.org/10.1155/2022/3601942

Ejemplares similares

Association between baseline C‑reactive protein level and survival outcomes for cancer patients treated with immunotherapy: A meta‑analysis
por: Xu, Yu, et al.
Publicado: (2023)

Daratumumab provides a survival benefit in relapsed and refractory Multiple Myeloma, independent of baseline clinical characteristics: A meta‐analysis
por: Cao, Congcong, et al.
Publicado: (2021)

Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival
por: Zarogoulidis, Paul, et al.
Publicado: (2023)

Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)
por: Vita, Emanuele, et al.
Publicado: (2023)

Baseline characteristics associated with survival in patients with hepatocellular carcinoma
por: Aslanov, Seymur, et al.
Publicado: (2021)

Mechanism and clinical application of thymosin in the treatment of lung cancer
por: Liu, Yafeng, et al.
Publicado: (2023)

Adoptive immunotherapy shows encouraging benefit on non-small cell lung cancer: a systematic review and meta-analysis
por: Zhao, Binghao, et al.
Publicado: (2017)

Baseline tumour measurements predict survival in advanced non-small cell lung cancer
por: Gerber, D E, et al.
Publicado: (2013)

Morning Hypertension in Treated Hypertensives: Baseline Characteristics and Clinical Implications
por: Lee, Ju-Hee, et al.
Publicado: (2011)

Systematic review and meta-analysis of the benefit of celecoxib in treating advanced non-small-cell lung cancer
por: Yi, Lilan, et al.
Publicado: (2018)

Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2020)

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study
por: Huang, Jian, et al.
Publicado: (2023)

Identification of combinations of somatic mutations that predict cancer survival and immunotherapy benefit
por: Gussow, Ayal B, et al.
Publicado: (2021)

Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy
por: Brilli, L., et al.
Publicado: (2020)

Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non‐small cell lung cancer patients
por: Song, Peng, et al.
Publicado: (2020)

Effect of baseline cancer pain on the efficacy of immunotherapy in lung cancer patients
por: Zhou, Huan, et al.
Publicado: (2023)

Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
por: Li, Yuanfang, et al.
Publicado: (2023)

Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail
por: Cali Daylan, Ayse Ece, et al.
Publicado: (2023)

Response to first‐line treatment predicts progression‐free survival benefit of small‐cell lung cancer patients treated with anlotinib
por: Qin, Boyu, et al.
Publicado: (2021)

Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
por: De Giglio, Andrea, et al.
Publicado: (2022)

Immunotherapy Benefit in a Patient With Non-Small Cell Lung Cancer and a Rare BRAF Mutation
por: Rittberg, Rebekah, et al.
Publicado: (2020)

B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients
por: Stefanski, Ana-Luisa, et al.
Publicado: (2022)

Immune-Related Adverse Events Are Associated With Clinical Benefit in Patients With Non-Small-Cell Lung Cancer Treated With Immunotherapy Plus Chemotherapy: A Retrospective Study
por: Morimoto, Kenji, et al.
Publicado: (2021)

The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms
por: Sugawara, Norio, et al.
Publicado: (2020)

Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials
por: Laporte, Silvy, et al.
Publicado: (2013)

Predictive value of baseline metabolic tumor volume for non-small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis
por: Zhu, Ke, et al.
Publicado: (2022)

Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review
por: Kim, Bum Jun, et al.
Publicado: (2017)

Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer
por: Hue, Jonathan J., et al.
Publicado: (2021)

A bibliometric analysis of Mediterranean diet on cancer from 2012 to 2021
por: Liu, Yafeng, et al.
Publicado: (2023)

Cancer immunotherapy: Benefit and harm?
por: Characiejus, Dainius
Publicado: (2012)

Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer
por: Ding, Xiao, et al.
Publicado: (2015)

Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy
por: Assi, Hussein A, et al.
Publicado: (2020)

Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer
por: Oronsky, Bryan, et al.
Publicado: (2018)

Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma
por: Zeng, Yu, et al.
Publicado: (2022)

Long-term Survival of Locally Advanced Stage III Non-small Cell Lung Cancer Patients Treated with Chemoradiotherapy and Perspectives for The Treatment with Immunotherapy
por: Vrankar, Martina, et al.
Publicado: (2018)

A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study
por: Yolchuyeva, Sevinj, et al.
Publicado: (2023)

Immune Pathways with Aging Characteristics Improve Immunotherapy Benefits and Drug Prediction in Human Cancer
por: Wang, Xinyue, et al.
Publicado: (2023)

Treated incidence and baseline characteristics of substance induced psychosis in a Norwegian catchment area
por: Weibell, Melissa A, et al.
Publicado: (2013)

Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
por: Rocco, Danilo, et al.
Publicado: (2023)

High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study
por: Fritszching, Benedikt, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gmncdmdqnqnsk5oj6ik1nf6jjo